MEDI-8852

N/A

Report date: 2025/04/14 16:57:30

Base Information

Drug NameMEDI-8852

Drug Alias NameMEDI-8852

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionImmunomodulatorsInfluenza virus hemagglutinin glycoproteins inhibitors

TargetsInfluenza virus hemagglutinin glycoproteins

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSouth Africa

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMedimmune Llc

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

ATC CodeN/A